Ephrin type A receptor 2 (EphA2) is expressed in paediatric sarcomas and paediatric high-grade gliomas (HGGs), glioblastoma multiforme, breast cancer, NSCLC and oesophageal cancer. Here, EPHA2 is linked to non-small cell lung carcinoma.